This inventor holds 4 USPTO granted patents. Top assignees: Sanofi, Sanofi-Aventis. Active years: 2011-2013.
Location History:
- Antony, FR (2011)
- Paris, FR (2012 - 2013)
- Rueil Malmaison, FR (2013)
Company Filing History:
Years Active: 2011-2013
Title: The Innovative Contributions of Francois Pacquet
Introduction
Francois Pacquet is a notable inventor based in Paris, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that modulate important biological processes. With a total of 4 patents to his name, Pacquet's work has the potential to impact the treatment of various metabolic disorders.
Latest Patents
One of his latest patents is titled "Tetrahydroquinoxaline urea derivatives as modulators of 11β-hydroxysteroid dehydrogenase type 1." This invention relates to a compound that is useful in modulating the activity of 11βHSD1, which is beneficial for treating conditions such as metabolic syndrome and noninsulin-dependent type 2 diabetes. The patent also covers pharmaceutical preparations containing this compound, as well as processes for its preparation and intermediates useful in the synthesis of the compound. Another significant patent is focused on "Substituted adamantanes and their therapeutic application," which also involves tetrahydroquinoxaline urea derivatives and their therapeutic uses.
Career Highlights
Francois Pacquet has worked with prominent companies in the pharmaceutical industry, including Sanofi and Sanofi-Aventis. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in medical treatments.
Collaborations
Throughout his career, Pacquet has collaborated with esteemed colleagues such as Claudie Namane and Eric Nicolai. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and enhances the development of innovative solutions.
Conclusion
Francois Pacquet's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in the treatment of metabolic disorders.